An exploratory, open-label, investigator-initiated study of interleukin-17 blockade in patients with moderate-to-severe papulopustular rosacea

BRITISH JOURNAL OF DERMATOLOGY

WILEY

1. Novartis
2. Stanford Medical Scholars Fellowship Program research award
3. Dermatology Foundation Medical Dermatology Career Development Award
4. Taipei Medical University
5. Stanford University